Assessment of cognitive-motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non-pharmacological intervention: A randomized double-blind placebo controlled trial.

The short version

This 2023 randomized controlled trial investigated the effects of remote biofield energy therapy on cognitive and motor functions in adults with perceived neuropsychological problems. Biofield energy therapy is a non-pharmacological intervention that utilizes the energy surrounding and permeating the human body to enhance healing and well-being. The study involved 114 participants aged 20 to 55 years, who were randomly assigned to three groups: a control group, a sham control group, and a biofield intervention group. Cognitive and motor functions were assessed using the NIH Toolbox at baseline (day 0), day 90, and day 180. Results indicated that the biofield intervention group experienced significant improvements in language function (p < 0.0001), working memory (p < 0.0001), and episodic memory (p < 0.0001) scores compared to both the control and sham control groups. Additionally, significant enhancements were observed in locomotion, standing balance, dexterity, grip strength, and muscle endurance (p < 0.05 to p < 0.0001). No adverse effects were reported, suggesting that remote biofield energy therapy is a safe and effective non-invasive intervention for improving cognitive and motor functions in adults with neuropsychological impairments. However, this study had limitations, including a small sample size and the need for further research to validate these findings across diverse populations and settings. Larger randomized controlled trials are necessary to establish the efficacy and mechanisms of biofield energy therapy in clinical practice.

Key findings

• Remote biofield energy therapy can significantly improve cognitive functions like language and memory.
• Participants showed enhanced motor skills, including balance and dexterity, after treatment.
• The therapy is safe with no reported adverse effects, making it a viable non-invasive option.